Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 4:57 pm Purchase |
2021-12-31 | 13G | eHealth, Inc. EHTH |
Palo Alto Investors LP | 1,615,570 6.120% |
1,615,570![]() (New Position) |
Filing History |
2021-02-16 4:49 pm Sale |
2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Palo Alto Investors LP | 4,230,548 7.740% |
-294,928![]() (-6.52%) |
Filing History |
2021-02-16 4:44 pm Sale |
2020-12-31 | 13G | STAAR Surgical Company STAA |
Palo Alto Investors LP | 2,849,348 6.180% |
-929,590![]() (-24.60%) |
Filing History |
2021-02-16 4:41 pm Purchase |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LP | 351,177 7.160% |
44,843![]() (+14.64%) |
Filing History |
2021-02-16 4:38 pm Sale |
2020-12-31 | 13G | Insmed Incorporated INSM |
Palo Alto Investors LP | 6,105,980 5.990% |
-742,780![]() (-10.85%) |
Filing History |
2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Epizyme, Inc. EPZM |
Palo Alto Investors LP | 6,738,913 6.630% |
592,968![]() (+9.65%) |
Filing History |
2021-02-16 4:29 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Palo Alto Investors LP | 4,469,411 5.060% |
-586,875![]() (-11.61%) |
Filing History |
2021-02-16 4:24 pm Sale |
2020-12-31 | 13G | AMAG PHARMACEUTICALS INC AMAG |
Palo Alto Investors LP | 0 0.000% |
-3,045,065![]() (Position Closed) |
Filing History |
2021-02-16 4:20 pm Purchase |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Palo Alto Investors LP | 802,423 15.640% |
802,423![]() (New Position) |
Filing History |
2021-02-16 4:14 pm Sale |
2020-12-31 | 13G | AIMMUNE THERAPEUTICS INC AIMT |
Palo Alto Investors LP | 0 0.000% |
-3,380,441![]() (Position Closed) |
Filing History |